Invengene secures regulatory approval for their Sugammadex Injectable
Invengene bridges innovation with global healthcare solutions, delivering advanced therapies from development to commercialization.

Invengene bridges innovation with global healthcare solutions, delivering advanced therapies from development to commercialization.
Invengene secures regulatory approval for their Sugammadex Injectable
Lorem ipsum dolor sit amet consectetur. tell us lorem senectus Lorem ipsum dolor sit amet consectetur.
Presence in 45+ countries across the world
20+ products in various stages of development
14 dossiers approved,
30 filed globally
25,000 sq. ft. dedicated injectables R&D centre
Driving innovation, protection, and trust across every stage of development.
Pioneering pharmaceutical formulation solutions across liposomes, emulsions, peptides, lyophilized products, and long-acting injectables to meet critical healthcare needs.
Driving innovation, protection, and trust across every stage of development.
Pioneering pharmaceutical formulation solutions across liposomes, emulsions, peptides, lyophilized products, and long-acting injectables to meet critical healthcare needs.
Strategic formulation selection emphasizing intellectual property and differentiation, ensuring market readiness and competitive advantage.
Reliable collaborations with major pharma, specialty pharma, and generics companies, built on integrity, transparency, and consistent delivery.
Use our intuitive search tool to find the product of interest
Use our intuitive search tool to find the product of interest by therapeutic category, api type & formulation.
Lorem ipsum dolor sit amet consectetur. lorem senectus Lorem ipsum dolor sit amet consectetur.